Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02452892 · ClinicalTrials.gov registry record · NA

Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)

A NA study of Depression and Depressive Disorder, Major, sponsored by Tal Medical.

Completed
Registry status
NA
Development phase
122
Enrollment target
12
Study locations

NCT02452892 is a NA study of Depression and Depressive Disorder, Major that has completed, run by Tal Medical. The registered enrollment target is 122 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (84% lower). The trial reports 12 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02452892, a NA study of Depression and Depressive Disorder, Major, has completed, sponsored by Tal Medical.

COMPLETED
Registry status
NA
Development phase
122 participants
Enrollment target
12
Study locations

Study Summary

The purpose of this study is to compare the relative effectiveness of 20 and 60 minutes of Low-Field Magnetic Stimulation in relieving symptoms in patients with major depression who are treatment resistant.

Interventions

  • DEVICE LFMS

Study Locations (12)

California

  • CNS Trials - Garden Grove
  • Synergy Escondido - Lemon Grove
  • Pacific Trials Partners - Oakland

Florida

  • Sarkis Clinical Trials - Gainesville
  • CNS Healthcare - Jacksonville
  • Segal Institute - Lauderhill

Georgia

  • Institute for Advanced Medical Research - Alpharetta
  • Radiant Research - Atlanta

Ohio

  • Neurobehavioral-Clinical Research - Canton
  • Midwest Clinical - Dayton

Texas

  • Future Search Trials - Dallas

Washington

  • Northwest Clinical Research Center - Bellevue

Trial Details

FieldValue
Enrollment Target 122 participants
Start Date 2015-09
Est. Completion 2016-10
Phase NA

Sponsor

Tal Medical

1 total trials

What the Registry Record Tells You About NCT02452892

The ClinicalTrials.gov registry entry for NCT02452892 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (84% lower). The listed sponsor is Tal Medical, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which LFMS is the first listed.

NCT02452892 reports 12 study locations spanning 6 distinct geographic areas - top geographies include California, Florida, Georgia.

Frequently Asked Questions

What is clinical trial NCT02452892 about?

NCT02452892 is a clinical study titled "Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)". The purpose of this study is to compare the relative effectiveness of 20 and 60 minutes of Low-Field Magnetic Stimulation in relieving symptoms in patients with major depression who are treatment resistant.

What is the current status of trial NCT02452892?

This trial is currently completed. It is a NA study. The enrollment target is 122 participants. The study started on 2015-09. Estimated completion is 2016-10.

What conditions does trial NCT02452892 study?

This clinical trial studies the following conditions: Depression, Depressive Disorder, Major, Depressive Disorder, Depressive Disorder, Treatment-Resistant.

What interventions are being tested in trial NCT02452892?

The interventions under investigation include: LFMS (DEVICE).

Who is sponsoring clinical trial NCT02452892?

This trial is sponsored by Tal Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02452892 being conducted?

This trial has 12 study locations across California, Florida, Georgia, Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.